Furuya Yoichi, Kirimanjeswara Girish S, Roberts Sean, Racine Rachael, Wilson-Welder Jennifer, Sanfilippo Alan M, Salmon Sharon L, Metzger Dennis W
Department of Immunology and Microbial Disease, Albany Medical College, Albany, NY 12208, USA.
Department of Immunology and Microbial Disease, Albany Medical College, Albany, NY 12208, USA.
Vaccine. 2017 Sep 5;35(37):4997-5005. doi: 10.1016/j.vaccine.2017.07.071. Epub 2017 Jul 31.
We report that IgA mice exhibit specific defects in IgG antibody responses to various polysaccharide vaccines (Francisella tularensis LPS and Pneumovax), but not protein vaccines such as Fluzone. This defect further included responses to polysaccharide-protein conjugate vaccines (Prevnar and Haemophilus influenzae type b-tetanus toxoid vaccine). In agreement with these findings, IgA mice were protected from pathogen challenge with protein- but not polysaccharide-based vaccines. Interestingly, after immunization with live bacteria, IgA and IgA mice were both resistant to lethal challenge and their IgG anti-polysaccharide antibody responses were comparable. Immunization with live bacteria, but not purified polysaccharide, induced production of serum B cell-activating factor (BAFF), a cytokine important for IgG class switching; supplementing IgA cell cultures with BAFF enhanced in vitro polyclonal IgG production. Taken together, these findings show that IgA deficiency impairs IgG class switching following vaccination with polysaccharide antigens and that live bacterial immunization can overcome this defect. Since IgA deficient patients also often show defects in antibody responses following immunization with polysaccharide vaccines, our findings could have relevance to the clinical management of this population.
我们报告称,IgA缺陷小鼠对多种多糖疫苗(土拉弗朗西斯菌脂多糖和肺炎疫苗)的IgG抗体反应存在特定缺陷,但对诸如流感疫苗等蛋白质疫苗则无此缺陷。这种缺陷还包括对多糖-蛋白质结合疫苗(沛儿疫苗和b型流感嗜血杆菌-破伤风类毒素疫苗)的反应。与这些发现一致的是,IgA缺陷小鼠可通过蛋白质疫苗而非多糖疫苗抵御病原体攻击。有趣的是,用活细菌免疫后,IgA缺陷和野生型IgA小鼠均对致死性攻击具有抗性,且它们的IgG抗多糖抗体反应相当。用活细菌而非纯化多糖进行免疫可诱导血清B细胞激活因子(BAFF)的产生,BAFF是一种对IgG类别转换很重要的细胞因子;用BAFF补充IgA缺陷小鼠的细胞培养物可增强体外多克隆IgG的产生。综上所述,这些发现表明,IgA缺陷会损害多糖抗原疫苗接种后的IgG类别转换,而活细菌免疫可克服这一缺陷。由于IgA缺陷患者在接种多糖疫苗后也常常表现出抗体反应缺陷,我们的发现可能与该人群的临床管理相关。